Cargando…
Efficacy and safety of dutasteride compared with finasteride in treating males with benign prostatic hyperplasia: A meta-analysis of randomized controlled trials
The present study was an updated meta-analysis that aimed to confirm the efficacy and safety of dutasteride (0.5 mg) and finasteride (5 mg) in treating males with benign prostatic hyperplasia (BPH) over a treatment period of at least 6 months. Randomized controlled trials were retrieved using the ME...
Autores principales: | Zhou, Zhongbao, Cui, Yuanshan, Wu, Jitao, Jin, Hairong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388259/ https://www.ncbi.nlm.nih.gov/pubmed/32742388 http://dx.doi.org/10.3892/etm.2020.8851 |
Ejemplares similares
-
Meta-analysis of the efficacy and safety of combination of tamsulosin plus dutasteride compared with tamsulosin monotherapy in treating benign prostatic hyperplasia
por: Zhou, Zhongbao, et al.
Publicado: (2019) -
The efficacy and safety of dutasteride compared with finasteride in treating men with androgenetic alopecia: a systematic review and meta-analysis
por: Zhou, Zhongbao, et al.
Publicado: (2019) -
The efficacy and safety of dutasteride and finasteride in patients with benign prostatic hyperplasia: a systematic review and meta-analysis
por: Li, Yao, et al.
Publicado: (2022) -
Rates of prostate surgery and acute urinary retention for benign prostatic hyperplasia in men treated with dutasteride or finasteride
por: Kuiper, Josephina G., et al.
Publicado: (2016) -
Meta-Analysis of Efficacy and Safety of Tadalafil Plus Tamsulosin
Compared with Tadalafil Alone in Treating Men with Benign Prostatic Hyperplasia
and Erectile Dysfunction
por: Zhou, Zhongbao, et al.
Publicado: (2019)